CLINICAL_TRIALS
trial_result
· 2022-07-27
Clinical Trial Update: Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color [Phase 4]
Summary
Phase 4 clinical trial update evaluating Aczone Gel 7.5% for acne vulgaris in patients with skin of color has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2022-07-27